Several BER genes, including APE1, POLβ and XRCC1, are overexpressed in multiple cancer types, such as prostate, cervical, non-small cell lung, ovarian, glioma, triple-negative breast and BCs14–33, suggesting that alterations in BER gene expression can influence disease susceptibility, initiation, and progression. This evidence concerns the gene POLB and cancer.